In essential thrombocythemia (ET), patient-derived platelets exhibit elevated ROS levels compared with those from healthy controls, promoting platelet activation, apoptosis, and fibrosis through activation of the JAK–STAT signaling pathway. The gene discussed is SOAT1; the disease is essential thrombocythemia.